Search results
It's Unlikely That The CEO Of Smartsheet Inc. (NYSE:SMAR) Will See A Huge Pay Rise This Year
Simply Wall St. via Yahoo Finance· 8 hours agoWe've identified 1 warning sign for Smartsheet that investors should be aware of in a dynamic...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 1 day agoPfizer's efforts in oncology look promising, with oncology product revenue climbing 19% in the most...
A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club
CNBC· 23 hours agoEli Lilly became the most valuable health-care company in the world on the back of its blockbuster...
Why Does Hollywood Care About Box Office Opening Weekends?
Variety· 4 hours agoActor Patrick Schwarzenegger (who has no discernible connection to the film) prophesied this staying...
Is This Trend a Threat to Eli Lilly's Weight Loss Drug Dominance? | The Motley Fool
The Motley Fool· 5 days agoLilly sells a broad range of medicines, but what lately has struck the fancy of investors -- and...
Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential
InvestorPlace via Yahoo Finance· 7 days agoThe biotech sector has been through a lot in the past five years and it is finally rebounding. One...
Power Lawyers 2024: Meet Hollywood’s Top 100 Attorneys
The Hollywood Reporter via Yahoo News· 5 hours agoMeet the dealmakers and litigators who made the cut for THR‘s 18th annual list of the entertainment...
Why Regeneron Stock Finally Joined The 1,000-Club
Investor's Business Daily· 5 hours agoEnthusiasm is growing for a looming approval in COPD treatment.
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 1 day agoNotably, Mounjaro generated $5.16 billion in sales, jetting higher from $482.5 million in 2022...
Nvidia Just Announced a Stock Split. History Says This Is What Happens Next.
Motley Fool via Yahoo Finance· 5 days agoBut splits tend to emerge at a point of strength rather than weakness, and that seems to apply to...